home icon user icon
Welcome to International Network for Natural Sciences | INNS Pub.
Home My Account
Submit Manuscript
double_slash
breadcumb_bg

Genotyping of Helicobacter pylori isolates from Egyptian Patients

Paper Details

Research Paper 01/04/2017
Views (315) Download (88)
current_issue_feature_image
publication_file

Genotyping of Helicobacter pylori isolates from Egyptian Patients

Eman M. Abd El Azeem, Abdel-Rahman B. Abdel-Ghaffar, Maha Hassan Shokaeir, Hend Abdelmoniem Ali
Int. J. Biosci.10( 4), 121-128, April 2017.
Certificate: IJB 2017 [Generate Certificate]
Key: babA2cagA genotypingGastritisHelicobactor pyloriPeptic ulcer

Abstract

The cag AandbabA2genes are the common virulence determinants of Helicobactor pylori (H. pylori). Acquiring virulent strains of H. pylori is associated with increased risk for the development of gastric ulcers or cancer. This study was carried out to investigate the prevalence of cytotoxin associated gene A (cagA) and blood adhesion binding antigen (babA2) genotypes of H. pylori isolates from Egyptian patients and its correlation with the sensitivity to antibiotics included in triple therapy. Culture of stool specimens was performed in stool samples obtained from 60 patients positive for H. pylori antigen in stool. DNA was extracted from H. pylori pure cultures. Genotyping was performed by PCR, using specific primers for, cagA and babA2 genes. Disc diffusion method was used to determine the sensitivity of cultured bacteria to amoxillin (AMX), metronidazole (MTZ) and clarithromycin (CLM). cagA was detected in 34.78% of isolates, while the bab7 allele of babA2 gene was detected in 43.47%isolates.13% of strains were genotype A (cagA+/babA2+), 21.7% of strains were genotype B (cagA+/babA2-), 30.4 % of strains were genotype C (cagA-/babA2+) and  34.8%of strains were genotype D (cagA-/babA2-). The highest prevalence of sensitivity was for AMX 52.2%, while MTZ was the lowest sensitivity prevalence 30.4%, when compared to the mean sensitivity prevalence of both concentrations of CLR (39.15%). According to these finding Genotyping combination (cagA-/babA2-) is the most prevalent and MTZ is not the optimal choice for the treatment of Egyptian patients and should not be included in the treatment regimens for H. pylori in Egypt.

VIEWS 7
Cover PDF

Abdullah M, Ohtsuka H, Rani A, Sato T, Syam A, Fujino M. 2009. Helicobacter pylori infection and gastropathy: a comparison between Indonesian and Japanese patients. World Journal of Gastroenterology. 15(39), 4928-4931, 4928-4931. http://dx.doi.org/10.3748/wjg.15.4928

Al Qabandi  A, Mustafa A, Siddique I, Khajah A, Madda J,  Junaid T. 2005.  Distribution of vacA and cagA  genotypes of Helicobacter pylori in Kuwait. Acta Tropica 93(3), 283-288. http://dx.doi.org/10.1016/j.actatropica.2005.01.004

Amer F, El-Sokkary R, Elahmady M, Gheith T, Abdelbary E, Elnagar Y, Abdalla W. 2013. Helicobacter pylori genotypes among patients in a university hospital in Egypt: identifying the determinants of disease severity. Journal of Microbiology and Infectious Diseases. 3(3), 109-115. http://dx.doi.org/10.5799/ahinjs.02.2013.03.0092.

Ben Mansour K, Fendri C, Zribi M, Masmoudi A, Labbene M, Fillali A, Ben Mami N, Najjar T, Meherzi A, Sfar T, Burucoa C. 2010. Prevalence of Helicobacter pylori vacA, cagA, iceA and oipA genotypes in Tunisian patients. Annals of Clinical Microbiology and Antimicrobials 9, 10. http://dx.doi.org/10.1186/1476-0711-9-10.

Diab M, Shemis M, El-Ghannam M, Gamal D, Azmy M, Salem D, Mansy S,  Saber M. 2016. Helicobacter pylori vacA genotyping in relation to cagA status, ultra-structure of gastric mucoA sa and clinical outcomes in Egyptian patients. African Journal of Microbiology Research. 10(14), 465-472. http://dx.doi.org/10.5897/AJMR2015.7693

Go M, Crowe S. 2000.Virulence and pathogenicity of Helicobacter pylori. Gastroenterology Clinics 29(3), 649-670. http://dx.doi.org/10.1016/S0889-8553(05)70136-9

Graham D, Fischbach L. 2010. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 59(8), 1143-1153. http://dx.doi.org/10.1136/gut.2009.192757

Hatakeyama M. 2014.Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe. 15(3), 306-16. http://dx.doi.org/10.1016/j.chom.2014.02.008.

Hatakeyama M. 2006. The role of Helicobacter pylori CagA in gastric carcinogenesis. International  Journal of Hematology 84(4), 301-308. http://dx.doi.org/10.1532/IJH97.06166

Hussein N, Mohammadi M, Talebkhan Y, Doraghi M, Letley D, Muhammad M, Argent R, Atherton J. 2008. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori associated disease. Journal Clinical Microbiology 46(5), 1774-1779. http://dx.doi.org/10.1128/JCM.01737-07.

Johannes G, Arnoud H, Ernst J. 2006. Pathogenesis of Helicobacter pylori Infection. Clinical Microbiology Review 19(3), 449–490. http://dx.doi.org/10.1128/CMR.00054-05.

Khalifa M, Sharaf R,  Aziz R. 2010.Helicobacter pylori: a poor man’s gut pathogen? Gut Pathology. 2(1), 2. http://dx.doi.org/10.1186/1757-4749-2-2

Malnick S, Melzer E, Attali M, Duek G, Yahav J. 2014. Helicobacter pylori: friend or foe? World Journal of Gastroenterology 20(27), 8979-8985. http://dx.doi.org/10.3748/wjg.v20.i27.8979

Matos J, de Sousa H, Marcos-Pinto R, Dinis-Ribeiro M. 2013.Helicobacter pylori cagA and vacA genotypes and gastric phenotype: a meta-analysis. European Journal of Gastroenterology & Hepatology. 25, 1431-1441. http://dx.doi.org/10.1097/MEG.0b013e328364b53e

Mattar  R, dos Santos  A, Eisig  J, Rodrigues T, Silva  F, Lupinacci  R, Iriya  K, Carrilho  F. 2005. No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil. Helicobacter . 10(6), 601-608. http://dx.doi.org/10.1111/j.1523-5378.2005.00360.x

Mottaghi B, Safaralizadeh R, Bonyadi M, Latifi-Navid S, Somi M. 2016. Helicobacter pylori vacA i region polymorphism but not babA2 status associated to gastric cancer risk in northwestern Iran. Clinical Experimental Medicine 16(1), 57–63. http://dx.doi.org/10.1007/s10238-014-0327-0

Ndip R, Malange- Takang A, Ojongokpoko J, Luma H, Malongue A, Akoachere J, Ndip L, MacMillan M, Weaver L. 2008. Helicobacter pylori isolates recovered from gastric biopsies of patients with gastroduodenal pathologies in Cameroon: current status of antibiogram. journal of tropical medicine and international health 13, 848-854. http://dx.doi.org/10.1111/j.1365-3156.2008.02062.x

Ousman S, Douglas E, Martin A, Tumani C, Mary T, Robert W, Vivat T, Juan J, Galano J, Richard A, Julian E. 2013. Antimicrobial Susceptibility and Resistance      Patterns among Helicobacter pylori Strains from The Gambia, West Africa. Antimicrobial Agents and Chemotherapy. 57(3), 1231–1237 http://dx.doi.org/10.1128/AAC.00517-12

Ozbey G,  Aygun C. 2012. Prevalence of genotypes in Helicobacter pylori isolates from patients in eastern Turkey and the association of these genotypes with clinical outcome. Brazilian Journal of Microbiology. 43(4), 1332-1339. http://dx.doi.org/org/10.1590/S151783822012000400014

Paniagua G, Monroy E, Rodriguez R, Arroniz S, Rodriguez C, Cortes J, Camacho A, Negrete E,  Vaca S. 2009. Frequency of vacA, cagA and babA2 virulence markers in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis. Annals of Clinical Microbiology and Antimicrobials. 30(8), 14. http://dx.doi.org/10.1186/1476-0711-8-14.

Rimbara E, Fischbach L, Graham D. 2011.Optimal therapy for Helicobacter pylori infections. Nature reviews. Gastroenterology & hepatology. 8(2), 79-88. http://dx.doi.org/10.1038/nrgastro.

Saxena A, Shukla S, Prasad KN, Ghoshal UC. 2011. Virulence attributes of Helicobacter pylori isolates & their association with gastroduodenal disease. Indian Journal of Medical Research. 133, 514-520.

Seck A, Mbengue M, Gassama-Sow A, Diouf L, Ka M, Boye C. 2009. Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal. Journal of Infection in Developing Countries. 3(2), 137–140.

Sheu B, Sheu S, Yang H, Huang A, Wu J. 2003.Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut. 52(7), 927-932.

Tanih N, McMillan M, Naidooc N, Ndipd L, Weaver L, Ndip RN. 2010.Prevalence of Helicobacter pylori vacA, cagA, and iceA genotypes in South African patients with upper gastrointestinal diseases. Acta Tropica. 116(1), 68 –73. http://dx.doi.org/10.1016/j.actatropica.2010.05.011

Torres LE, Melian K, Moreno A, Alonso J, Sabatier C, Hernandez M, Bermudez ,L Rodriguez B. 2009.Prevalence of vac A, cag A and babA2 genes in Cuban Helicobacter pylori isolates. World Journal of Gastroenterology. 15(2), 204-210. http://dx.doi.org/10.3748/wjg.15.204

Wen S, Moss S. 2009. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Letter. 282(1), 1-8. http://dx.doi.org/10.1016/j.canlet.2008.11.016.

Xu C, Li Z, Tu Z, Xu G, Gong Y, Man X. 2003.Distribution of cag G gene in Helicobacter pylori isolates from Chinese patients with different gastroduodenal diseases and its clinical and pathological significance. World Journal of Gastroenterology 9(10), 2258-2260.

Yamaoka Y. 2010.Mechanisms of disease: Helicobacter pylori virulence factors. Nature reviews. Gastroenterology & hepatology . 7(11), 629-641. http://dx.doi.org/10.1038/nrgastro.2010.154.

Yu  J, Leung W, Go M, Chan M, To K, Ng E, Chan F, Ling T, Chung S, Sung J. 2002. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut. 51(4), 480-484.

Submit Manuscript